Spinal cord stimulation, often abbreviated SCS therapy, is a neuromodulation technique used to manage certain forms of chronic pain that have not responded adequately to more conservative treatments. Rather than removing or repairing damaged tissue, this chronic pain device approach works by altering how pain signals are processed as they travel through the spinal cord toward the brain.
What Is Neuromodulation and How Does It Apply to Pain?
Neuromodulation refers to techniques that alter nervous system activity through targeted delivery of electrical stimulation or other signals, rather than through medication or surgery aimed at a structural problem. In the context of chronic pain, spinal cord stimulation delivers mild electrical pulses to the dorsal, or back, portion of the spinal cord through thin electrode leads. These pulses are believed to interfere with or modify the transmission of pain signals traveling to the brain, and many patients describe the sensation as a mild tingling or, with certain newer stimulation patterns, no noticeable sensation at all, replacing or reducing their perception of pain.
What Conditions Is Spinal Cord Stimulation Used For?
Spinal cord stimulation is most commonly considered for chronic neuropathic pain conditions that have not responded well to other treatments, including persistent pain following spine surgery, sometimes called failed back surgery syndrome, complex regional pain syndrome, and certain types of peripheral neuropathic pain. It is generally reserved for patients who have already tried and not achieved adequate relief from more conservative options such as physical therapy, medications, and other interventional procedures, reflecting its position as a more advanced step in the chronic pain treatment pathway.
How Does the System Work Mechanically?
A spinal cord stimulation system generally consists of thin electrode leads placed near the spinal cord, typically through a minimally invasive needle-based technique or, in some cases, a small surgical incision, connected to a small pulse generator that is implanted under the skin, usually in the abdomen or upper buttock area. The generator delivers programmable electrical pulses to the leads, and settings can be adjusted after implantation to optimize pain relief for the individual patient. Many modern systems also include external, patient-controlled devices that allow limited adjustment of stimulation intensity or pattern within physician-set parameters.
Why Is a Trial Period Used Before Permanent Implantation?
Because individual response to spinal cord stimulation varies and cannot be reliably predicted in advance, a temporary trial period using externally connected leads is typically performed before a permanent system is implanted. This trial allows the patient and physician to assess whether the therapy provides meaningful pain relief and functional improvement over a period of several days to about a week. Only patients who experience a substantial reduction in pain during this trial generally proceed to permanent implantation, which helps avoid permanently implanting a device in patients unlikely to benefit.
Who Determines Candidacy for This Therapy?
Given the invasive nature of permanent implantation and the range of alternative treatments available, a qualified physician, often working within a multidisciplinary pain management team, determines candidacy for spinal cord stimulation based on the specific diagnosis, prior treatment history, psychological evaluation, and results of the trial period. This chronic pain device approach is not a first-line treatment and is not suitable for every type of pain, so careful patient selection is central to the overall treatment pathway.
Is spinal cord stimulation reversible if it does not help?
The trial phase is fully reversible, since the leads are simply removed if the trial does not provide adequate benefit. A permanently implanted system can also be surgically removed if needed, though this is a more involved procedure than removing trial leads.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.